Cancer Institute Translational Technology Platforms
The Cancer Institute Translational Technology Platforms (CI TTPs) provide scientific infrastructure for cutting edge basic, translational and clinical cancer services to support cancer researchers at UCL.
The Cancer Institute Translational Technology Platforms (CI TTPs) are underpinned by funding from the CRUK UCL Centre infrastructure grant and the Cancer Institute. As funding for the CI TTPs comes predominantly from the CRUK UCL Centre award, the CRUK UCL Centre is responsible for the overarching governance for all CI TTPs. The TTPs are open to CRUK UCL Centre members to support the Centre’s research programme. Funding for the CI TTPs also comes from the Experimental Cancer Medicine Centre (ECMC), National Institute of Health Research (NIHR) UCL Hospitals Biomedical Research Centre (BRC) and the Medical Research Council (MRC).
If you have any comments or queries regarding the CI TTPs, please contact us at: email@example.com.
The Bioinformatics Translational Technology Platform offers collaborative support to researchers at the UCL Cancer Institute and CRUK UCL Centre. The facility mainly focuses on genomics projects, but is gradually expanding to support other data types.
The NIHR UCLH Clinical Research Facility (CRF) facilitates the translation of basic science knowledge into improved patient care by providing support for developing and testing new diagnostics and therapies.
The Flow Cytometry Translational Technology Platform provides equipment and expertise in flow analysis, cell sorting and mass cytometry to cancer researchers.
The Good Clinical Laboratory Practice Facility (GCLP), working in partnership with the UCL Experimental Cancer Medicine Centre (ECMC), provides support for the analysis of clinical trial samples.
The Genomics and Genome Engineering Translational Technology Platform provides access to state-of-the-art genomics equipment, next-generation sequencing (NGS) library preparation, and affordable genome engineering services.
The UCL Cancer Institute Microscopy and Imaging Translational Technology Platform provides cutting edge imaging techniques to cancer researchers at the UCL.
The Pathology Services at the UCL Cancer Institute offer a range of pathology-based services, from processing to access to tissue samples.
The Preclinical Radiotherapy platform, with rotating X-ray gantry, combines cone beam CT imaging and x-ray microbeam targeting.
The Proteomics Research Translational Technology Platform offers collaborative proteomics research support for projects at the Cancer Institute and within the CRUK UCL Centre.